Neovasc (NVCN) Climbs 8.78% on June 21

Equities Staff  |

Shares of Neovasc Inc (NASDAQ: NVCN) are up 8.78% Tuesday.

As of 11:29:54 est, Neovasc sits at $5.45 and has climbed $0.44 so far today.

Neovasc has moved 9.40% over the last 30 days and has a YTD change of 57.23% based on the prior day’s close.

The company is set to release earnings on 2022-08-11.

For technical charts, analysis, and more on Neovasc visit the company profile.

About Neovasc Inc

Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and Tiara, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe.

To get more information on Neovasc Inc and to follow the company's latest updates, you can visit the company's profile page here: Neovasc Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content